Effectiveness and safety of second-line (2L) irinotecan- and oxaliplatin-based regimens after first-line (1L) bevacizumab (BV)-containing treatment (tx) for metastatic colorectal cancer (mCRC): ...
Frank A. Krueger (maker of Calca, a longtime favorite of mine) has launched Continuous, a new programming app for iOS. Continuous gives you the power of a traditional desktop .NET IDE - full C# 6 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback